ES2131805T3 - Derivados de benzoxacina, sus procedimientos de obtencion y su utilizacion como medicamentos. - Google Patents

Derivados de benzoxacina, sus procedimientos de obtencion y su utilizacion como medicamentos.

Info

Publication number
ES2131805T3
ES2131805T3 ES95906357T ES95906357T ES2131805T3 ES 2131805 T3 ES2131805 T3 ES 2131805T3 ES 95906357 T ES95906357 T ES 95906357T ES 95906357 T ES95906357 T ES 95906357T ES 2131805 T3 ES2131805 T3 ES 2131805T3
Authority
ES
Spain
Prior art keywords
group
formula
representing
pct
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95906357T
Other languages
English (en)
Inventor
Maurice-Bernard Fleury
Jean-Marc Maurette
Martine Largeron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Pharmascience SA
Original Assignee
Laboratoires Pharmascience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Pharmascience SA filed Critical Laboratoires Pharmascience SA
Application granted granted Critical
Publication of ES2131805T3 publication Critical patent/ES2131805T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Electrochemistry (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE LA BENZOXACINA, DE FORMULA (I) EN LA QUE: R{SUB,1} Y R{SUB,2}, INDEPENDIENTEMENTE UNO DE OTRO, REPRESENTAN UN GRUPO ALQUILO DE 1 A 3 ATOMOS DE CARBONO, O UN GRUPO DE FORMULA -CH{SUB,2}-OR}{SUB,A}, REPRESENTANDO R{SUB,A} UN ATOMO DE HIDROGENO O UN GRUPO METILO, R{SUB,X} REPRESENTA: UN GRUPO ALQUILO DE 1 A 3 ATOMOS DE CARBONO, PARTICULARMENTE UN GRUPO METILO, O UN GRUPO OR{SUB,X1}, REPRESENTANDO R{SUB,X1} UN GRUPO ALQUILO DE 1 A 3 ATOMOS DE CARBONO, PARTICULARMENTE UN GRUPO METOXI, O UN GRUPO DE FORMULA -CH{SUB,2-X EN LA QUE X REPRESENTA UN ATOMO DE HALOGENO, PARTICULARMENTE CLORO, O UN GRUPO DE FORMULA (A) EN LA QUE: R{SUB,3} Y R{SUB,5} INDEPENDIENTEMENTE UNO DE OTRO REPRESENTAN UN ATOMO DE HIDROGENO, O UN GRUPO -OH, O UN GRUPO -OCH{SUB,3}; R{SUB,4} REPRESENTA UN ATOMO DE HIDROGENO, O UN GRUPO -OR{SUB,B}, REPRESENTANDO R{SUB,B} UN ATOMO DE HIDROGENO O UN GRUPO METILO, O R{SUB,4} REPRESENTA UN GRUPO DE FORMULA OR{SUB,C}, REPRESENTANDO R{SUB,C} UN GRUPO DE FORMULA -CH{SUB,2}CO-C{SUB,6}H{SUB,4}R'' EN LA QUE R'' REPRESENTA UN ATOMO DE HIDROGENO, -CN O -OCH{SUB,3}; BIEN R{SUB,6} REPRESENTA UN GRUPO -OR{SUB,D}, REPRESENTANDO R{SUB,D} UN ATOMO DE HIDROGENO O UN GRUPO METILO, CUANDO R{SUB,7} Y R{SUB,8} SE ASOCIAN PARA FORMAR UN DOBLE ENLACE, BIEN R{SUB,8} REPRESENTA UN GRUPO -OR{SUB,E} EN EL QUE R{SUB,E} REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METILO, CUANDO R{SUB,6} Y R{SUB,7} SE ASOCIAN PARA FORMAR CON EL ATOMO DE CARBONO EN POSICION 8 DEL CICLO, UN GRUPO C = O, ASI COMO SUS PROCEDIMIENTOS DE OBTENCION. LA INVENCION APUNTA TAMBIEN A LAS COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN ESTOS DERIVADOS, Y SUS UTILIZACIONES PARTICULARMENTE EN EL MARCO DEL TRATAMIENTO DE PATOLOGIAS ASOCIADAS A LA PRESENCIA DE RADICALES LIBRES, Y MAS PARTICULARMENTE DE LA ENFERMEDAD DE ALZHEIMER.
ES95906357T 1993-12-29 1994-12-29 Derivados de benzoxacina, sus procedimientos de obtencion y su utilizacion como medicamentos. Expired - Lifetime ES2131805T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9315836A FR2714381B1 (fr) 1993-12-29 1993-12-29 Dérivés de la benzoxazine, leurs procédés d'obtention et leur utilisation en tant que médicaments .

Publications (1)

Publication Number Publication Date
ES2131805T3 true ES2131805T3 (es) 1999-08-01

Family

ID=9454544

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95906357T Expired - Lifetime ES2131805T3 (es) 1993-12-29 1994-12-29 Derivados de benzoxacina, sus procedimientos de obtencion y su utilizacion como medicamentos.

Country Status (11)

Country Link
US (1) US5804580A (es)
EP (1) EP0737187B1 (es)
JP (1) JPH09507483A (es)
AT (1) ATE179704T1 (es)
AU (1) AU1510495A (es)
DE (1) DE69418347T2 (es)
DK (1) DK0737187T3 (es)
ES (1) ES2131805T3 (es)
FR (1) FR2714381B1 (es)
GR (1) GR3030567T3 (es)
WO (1) WO1995018114A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2779144B1 (fr) * 1998-05-29 2000-06-30 Adir Nouveaux composes 8-amino-1,4-benzoxaziniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GR1007084B (el) * 2008-08-07 2010-11-26 Ευτυχια Κοϊνη 1,4- βενζοξαζινικα αναλογα
CN102552233B (zh) * 2011-12-26 2014-05-14 暨南大学 3,4-二羟基苯甲酸甲酯在制备防治神经退行性疾病药物中的应用
CN113106473B (zh) * 2021-04-14 2022-02-18 南京工业大学 一种通过连续电化学微反应器装置制备1,3-苯并噁嗪衍生物的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377202A2 (fr) * 1977-01-12 1978-08-11 Pharmascience Lab Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone
US4263322A (en) * 1979-03-01 1981-04-21 Riet Bartholomeus Van T Hydroxy benzohydroxamic acids and benzamides
FR2504917B1 (fr) * 1981-05-04 1987-09-25 Delalande Sa Nouveau systeme oxydant selectif et son application a la preparation de derives aromatiques ortho-dihydroxyles ou ortho-dialcoxyles
US4956372A (en) * 1987-10-02 1990-09-11 Kyorin Pharmaceutical Co., Ltd. Cyclic anthranilic acid derivatives and process for their preparation
US5124325A (en) * 1989-06-13 1992-06-23 Kyorin Pharmaceutical Co., Ltd. Therapeutic agents of metabolic bone disease
US5208247A (en) * 1991-08-01 1993-05-04 American Cyanamid Company Pyridinium compounds which are useful as antagonists of platelet activating factor

Also Published As

Publication number Publication date
ATE179704T1 (de) 1999-05-15
FR2714381A1 (fr) 1995-06-30
US5804580A (en) 1998-09-08
AU1510495A (en) 1995-07-17
DK0737187T3 (da) 1999-11-15
GR3030567T3 (en) 1999-10-29
JPH09507483A (ja) 1997-07-29
EP0737187A1 (fr) 1996-10-16
FR2714381B1 (fr) 1996-02-02
DE69418347T2 (de) 1999-11-18
EP0737187B1 (fr) 1999-05-06
WO1995018114A1 (fr) 1995-07-06
DE69418347D1 (de) 1999-06-10

Similar Documents

Publication Publication Date Title
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
SE7907121L (sv) Ftalimidinderivat
SE9100342D0 (sv) Novel steroid esters
HUP0302959A2 (hu) Nem-imidazol ariloxi-alkil-aminok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
SE8903226L (sv) Kemiska foereningar
ES2131805T3 (es) Derivados de benzoxacina, sus procedimientos de obtencion y su utilizacion como medicamentos.
FI953784A (fi) 3'-atsiridinoantrasykliinijohdannaiset
NO154391C (no) E 2-amino-naftalen-derivater.
ATE187169T1 (de) 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate
ES2069313T3 (es) Utilizacion de derivados de tiazoloisoindolinona como medicamentos antiviricos.
ES2094048T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
FI915928A0 (fi) Foerbaettrat foerfarande foer fram- staellning av ketonfoerendringar.
DE68902627D1 (de) Verwendung von chromanderivaten zur herstellung eines medikamentes zur behandlung von depressiven zustaenden.
ES2123785T3 (es) Nuevo procedimiento de preparacion de acido beta-alcoxi-acrilico.
DE69613783D1 (de) 4-(6-fluor-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-on-derivate,ihre herstellung und ihre verwendung in der behandlung von psychosen, schizophrenie und angstzuständen
ES511642A0 (es) "metodo de preparar sulfohalogenuros".
ATE5720T1 (de) 2-pyridyloxyacetanilid-verbindungen, verfahren zu ihrer herstellung und ihre verwendung.
ES2119454T3 (es) Derivados de pirrolidina para el tratamiento de los desordenes relacionados con la csk y la gastrina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 737187

Country of ref document: ES